Predictions
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€152.65
16.11.21
16.11.21
€200.00
31.01.25
31.01.25
36.59%
03.08.22
03.08.22
Could be worthwhile Investment >10% per year
Axsome Therapeutics Inc
Start price
Target price
Perf. (%)
€32.27
16.11.21
16.11.21
€25.00
16.11.22
16.11.22
59.84%
16.11.22
16.11.22
Could be very worthwhile Investment >20% year
Kezar Life Sciences
Start price
Target price
Perf. (%)
€10.20
16.11.21
16.11.21
€11.00
31.12.24
31.12.24
0.98%
28.06.22
28.06.22
Could be very worthwhile Investment >20% year
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€23.97
15.11.21
15.11.21
-
15.11.22
15.11.22
-28.16%
26.11.21
26.11.21
Could be worthwhile Investment >10% per year
Amarin Corp. ADR
Start price
Target price
Perf. (%)
€3.40
15.11.21
15.11.21
€2.00
31.12.23
31.12.23
-15.88%
16.12.21
16.12.21
Could be very worthwhile Investment >20% year
Valneva SE
Start price
Target price
Perf. (%)
€21.24
15.11.21
15.11.21
€25.00
15.11.22
15.11.22
33.24%
27.11.21
27.11.21
Fair valuation
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Higher risks for its business
Evofem Biosciences Inc.
Start price
Target price
Perf. (%)
€9.04
14.11.21
14.11.21
€4.50
31.12.23
31.12.23
-21.76%
16.11.21
16.11.21
Could be very worthwhile Investment >20% year
Curis Inc.
Start price
Target price
Perf. (%)
€5.06
14.11.21
14.11.21
-
14.11.22
14.11.22
-83.10%
15.11.22
15.11.22
Probably not worthwhile Investment
ALK-Abelló A/S B
Start price
Target price
Perf. (%)
€22.33
13.11.21
13.11.21
€24.00
13.11.22
13.11.22
-37.17%
14.11.22
14.11.22
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Hexo Corp.
Start price
Target price
Perf. (%)
€22.26
13.11.21
13.11.21
€28.00
13.11.22
13.11.22
-88.09%
14.11.22
14.11.22
Higher risks for its business
Catalyst Biosciences Inc
Start price
Target price
Perf. (%)
€0.79
13.11.21
13.11.21
€0.000
13.11.22
13.11.22
-26.11%
27.11.21
27.11.21
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
High valuation
Canopy Growth Corp
Start price
Target price
Perf. (%)
€13.55
13.11.21
13.11.21
-
13.11.22
13.11.22
-69.88%
14.11.22
14.11.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Innovative
Future proof or reliable business model
Apellis Pharmaceuticals
Start price
Target price
Perf. (%)
€37.80
13.11.21
13.11.21
€50.00
31.12.23
31.12.23
11.71%
29.06.22
29.06.22
Could be very worthwhile Investment >20% year
Catalyst Biosciences Inc
Start price
Target price
Perf. (%)
€0.89
12.11.21
12.11.21
-
12.11.22
12.11.22
-14.69%
15.11.21
15.11.21
Risky Investment
Genomic Vision S.A.
Start price
Target price
Perf. (%)
€0.30
12.11.21
12.11.21
€0.50
12.11.22
12.11.22
-78.55%
13.11.22
13.11.22
Could be worthwhile Investment >10% per year
Swedish Orphan Biovitrum Ab
Start price
Target price
Perf. (%)
€23.37
11.11.21
11.11.21
€28.00
11.11.22
11.11.22
-18.19%
12.11.22
12.11.22
Could be worthwhile Investment >10% per year
Novavax Inc.
Start price
Target price
Perf. (%)
€145.98
11.11.21
11.11.21
€75.00
11.11.22
11.11.22
-63.74%
11.04.22
11.04.22
Very low/no dividend yield expected
very negative Cash Flow expected
ROE lower than 10% per year
high free float
Nanobiotix
Start price
Target price
Perf. (%)
€8.51
11.11.21
11.11.21
€10.00
11.11.22
11.11.22
-53.17%
12.11.22
12.11.22
Could be worthwhile Investment >10% per year
Avenue Therapeutics Inc.
Start price
Target price
Perf. (%)
€16.95
11.11.21
11.11.21
€30.00
11.11.22
11.11.22
-21.68%
14.12.21
14.12.21
Could be worthwhile Investment >10% per year
Erytech Pharma S.A.
Start price
Target price
Perf. (%)
€2.19
11.11.21
11.11.21
-
11.11.22
11.11.22
2.28%
17.11.21
17.11.21
Could be worthwhile Investment >10% per year
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€533.60
09.11.21
09.11.21
€600.00
09.11.22
09.11.22
38.91%
10.11.22
10.11.22
Could be worthwhile Investment >10% per year